Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,545 | -9,932 | -30,527 | -23,306 | -14,787 |
| Depreciation Amortization | 17 | 10 | 41 | 30 | 20 |
| Other Working Capital | 2,899 | 1,171 | 3,957 | 4,041 | 1,294 |
| Other Operating Activity | 1,159 | 709 | 2,221 | 1,878 | 1,114 |
| Operating Cash Flow | $-15,470 | $-8,042 | $-24,308 | $-17,357 | $-12,359 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 30,000 | 20,000 | 10,000 |
| Common Stock Issued | N/A | N/A | 6,814 | 6,815 | 6,815 |
| Financing Cash Flow | $N/A | $N/A | $36,814 | $26,815 | $16,815 |
| Beginning Cash Position | 39,648 | 39,648 | 27,142 | 27,142 | 27,142 |
| End Cash Position | 24,178 | 31,606 | 39,648 | 36,600 | 31,598 |
| Net Cash Flow | $-15,470 | $-8,042 | $12,506 | $9,458 | $4,456 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,470 | -8,042 | -24,308 | -17,357 | -12,359 |
| Free Cash Flow | -15,470 | -8,042 | -24,308 | -17,357 | -12,359 |